Get it on Google Play

Stereotaxis receives FDA approval for robotic ablation catheter

January 6, 2026 8:02 AM EST Send to a Friend
Stereotaxis (NYSE: STXS) announced it received U.S. Food and Drug Administration approval for its MAGiC Magnetic Interventional Ablation Catheter on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login